Search

Current filters:
Add Filter:

Results

Customise results display
Item hits:
Issue DateTitleAuthor(s)
2020Failure to access prescribed pharmaceuticals by older patients with chronic conditionsMcRae, I; Van Gool, K; Hall, J; Yen, L; Wright, M
2020What happens to drug use and expenditure when cost sharing is completely removed? Evidence from a Canadian provincial public drug planLaba, T-L; Cheng, L; Worthington, HC; McGrail, K; Chan, FKI; Mamdani, M; Law, MR
2020-11Horizontal inequity in the utilisation of healthcare services in Australia.Pulok, MH; van Gool, K; Hall, J
2020-10Assessing the capacity of Ghana to introduce health technology assessment: a systematic review of economic evaluations conducted in Ghana.Addo, R; Goodall, S; Hall, J; Haas, M
2020-04-22Improving outcomes for marginalised rural families through an care navigator programKirby, S; Edwards, K; Yu, S; van Gool, K; Powell-Davies, G; Harris-Roxas, B; Gresham, E; Harris, M; Hall, J
2021-02-04Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications.Godman, B; Hill, A; Simoens, S; Selke, G; Selke Krulichová, I; Zampirolli Dias, C; Martin, AP; Oortwijn, W; Timoney, A; Gustafsson, L; Voncina, L; Kwon, H-Y; Gulbinovic, J; Gotham, D; Wale, J; Silva, WCD; Bochenek, T; Allocati, E; Kurdi, A; Ogunleye, OO; Meyer, JC; Hoxha, I; Malaj, A; Hierländer, C; Sauermann, R; Hamelinck, W; Petrova, G; Laius, O; Langner, I; Yfantopoulos, J; Joppi, R; Jakupi, A; Greiciute-Kuprijanov, I; Vella Bonanno, P; Piepenbrink, JH; de Valk, V; Wladysiuk, M; Marković-Peković, V; Mardare, I; Fürst, J; Tomek, D; Obach Cortadellas, M; Zara, C; Pontes, C; McTaggart, S; Laba, T-L; Melien Ø; Wong-Rieger, D; Bae, S; Hill, R
2020-01-01Chaos, border collisions and stylized empirical facts in an asset pricing model with heterogeneous agentsAnufriev, M; Gardini, L; Radi, D
2020Is there enough leisure time? Leisure studies, work-life balance, the realm of necessity and the realm of freedomVeal, AJ
2020-05Cost-effectiveness and financial risks associated with immune checkpoint inhibitor therapyKim, H; Liew, D; Goodall, S
2020Financial toxicity of childhood cancer and changes to parents’ employment after treatment completionKelada, L; Wakefield, CE; Vetsch, J; Schofield, D; Sansom-Daly, UM; Hetherington, K; O’Brien, T; Cohn, RJ; Anazodo, A; Viney, R; Zeppel, MJB
Results 1-10 of 26 (Search time: 0.043 seconds).